2002
DOI: 10.1046/j.1537-2995.2002.00146.x
|View full text |Cite
|
Sign up to set email alerts
|

Combined isolation of CD34+ progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods

Abstract: Combined positive and negative magnetic cell selection achieves a high grade of tumor cell reduction with up to 77 percent of the grafts being negative for tumor-specific clonal signal by PCR analysis. This technique preserves an adequate recovery of progenitor cells able to engraft.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2004
2004
2025
2025

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…They are based on the utilization of commercially available monoclonal anti-CD34 antibodies and are suitable for the isolation of highly purified CD34 + cells from various hematopoietic sources [ 72 , 73 , 74 , 75 ]. Immunomagnetic beads conjugated with monoclonal anti-CD34 antibodies have been reported, allowing for the efficient isolation of CD34 + progenitor cells from peripheral blood with a degree of purity >90% by use of a magnetic cell selector [ 76 ]. However, CD34 is expressed at low frequency not only in cells from peripheral and umbilical cord blood, but also in cells derived from tissues of non-hematopoietic origin and is therefore considered as general marker for diverse progenitor cells [ 70 , 77 ].…”
Section: Ex Vivo Generation Of Developing Erythrocytesmentioning
confidence: 99%
“…They are based on the utilization of commercially available monoclonal anti-CD34 antibodies and are suitable for the isolation of highly purified CD34 + cells from various hematopoietic sources [ 72 , 73 , 74 , 75 ]. Immunomagnetic beads conjugated with monoclonal anti-CD34 antibodies have been reported, allowing for the efficient isolation of CD34 + progenitor cells from peripheral blood with a degree of purity >90% by use of a magnetic cell selector [ 76 ]. However, CD34 is expressed at low frequency not only in cells from peripheral and umbilical cord blood, but also in cells derived from tissues of non-hematopoietic origin and is therefore considered as general marker for diverse progenitor cells [ 70 , 77 ].…”
Section: Ex Vivo Generation Of Developing Erythrocytesmentioning
confidence: 99%
“…The probability of relapse should drop with less contaminant cells but would likely remain nonzero even with a single cell. However, the contribution of these contaminating tumor cells to relapse of the cancer after treatment is still controversial (15,16). Helping to resolve this controversy by removing all contaminant cancer cells to eliminate this possible source of relapse motivates evaluation of the image cytometry method for purging 100% of the contaminant cells.…”
mentioning
confidence: 99%